High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma (clinicaltrials.gov) - Sep 30, 2026 - P3 | N=1150 | Completed | Sponsor: ECOG-ACRIN Cancer Research Group | Active, not recruiting ➔ Completed | Trial completion date: Dec 2026 ➔ May 2026
Trial completion • Trial completion date • Breast Cancer • Melanoma • Oncology • Solid Tumor
|